The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer

SIMPLE SUMMARY: Colorectal cancer is the third most commonly diagnosed cancer. Patients may receive chemotherapy, targeted therapy, immunotherapy, radiotherapy, and/or surgery. However, not all patients will benefit from each available treatment option. There has been rising interest in personalised...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Chang, Olsen, Kelly A., Bond, Catherine E., Whitehall, Vicki L. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913532/
https://www.ncbi.nlm.nih.gov/pubmed/36765763
http://dx.doi.org/10.3390/cancers15030805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913532/
https://www.ncbi.nlm.nih.gov/pubmed/36765763
http://dx.doi.org/10.3390/cancers15030805

Ejemplares similares